First AD

Second AD

Medical Content

Multiple Myeloma

BMS-22-OSD1240 - /clinical/multiple-myeloma

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Recent Advances in Molecular Biomarkers in Multiple Myeloma

OncLive Insights

Shaji Kumar, MD and Jonathan Kaufman, MD, discuss unmet needs in the multiple myeloma treatment landscape and share their insights on testing for biomarkers.

Future Perspectives in Biomarker Identification and Testing in MM

Biomarkers in Multiple Myeloma (MM): Overview

Role of t(11;14) Translocation in Patients with MM

Evidence Around BCL2 Inhibitors for Patients with t(11;14) Translocation in MM

Emerging Biomarkers in Multiple Myeloma

Testing for Biomarkers in Multiple Myeloma